Under the agreement, eResearchTechnology (eRT) and nSpire will deliver a combined solution to meet the increased demand for cardio-pulmonary safety and efficacy services during clinical trials, in part caused by an increased interest in using inhaled therapeutics. The partnership will offer integrated services from project planning and set-up through study conduct, management, and data delivery for primary and secondary cardiac and respiratory clinical trial endpoints.
nSpire Health will provide eSP Core Lab Data Management software, QA services, HDpft, KoKo, PiKo, and PiKoLogic (electronic diary) respiratory diagnostic measuring instruments. eRT will perform digital collection, measurement, interpretation, review, and distribution of cardiac safety data through its EXPeRT 2.0 workflow-enabled data management system.
Michael Sims, president and CEO of nSpire Health, said: “This partnership leverages cardio- respiratory specific technologies and data management services from each company into one unified source, reducing costs and accelerating time to market for emerging inhaled therapeutic trials.”